同源康医药-B拟折让19%配股总筹1.57亿港元 加码研发与商业化布局

格隆汇
Jul 29

格隆汇7月29日丨同源康医药-B(02410.HK)发布公告,2025年7月28日,公司与配售代理(即中信证券)订立配售协议,据此,配售代理有条件同意作为公司的配售代理,按尽力基准促使承配人按每股配售股份17.01港元的配售价购买923万股配售股份。预期配售代理将促使不少于6名承配人(将为专业、机构或其他投资者)认购配售股份。假设于本公告日期至交割日期期间已发行股份数目并无变动,则配售事项项下的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10